177 related articles for article (PubMed ID: 18847185)
21. Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives.
Carotti A; Catto M; Leonetti F; Campagna F; Soto-Otero R; Méndez-Alvarez E; Thull U; Testa B; Altomare C
J Med Chem; 2007 Nov; 50(22):5364-71. PubMed ID: 17910428
[TBL] [Abstract][Full Text] [Related]
22. Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
Org Biomol Chem; 2005 Jun; 3(11):2167-74. PubMed ID: 15917906
[TBL] [Abstract][Full Text] [Related]
23. Novel polycarbo-substituted alkyl (thieno[3,2-c]quinoline)-2-carboxylates: synthesis and cytotoxicity studies.
Mphahlele MJ; Maluleka MM; Makhafola TJ; Mabeta P
Molecules; 2014 Nov; 19(11):18527-42. PubMed ID: 25401397
[TBL] [Abstract][Full Text] [Related]
24. Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines.
Naylor MA; Stephens MA; Nolan J; Sutton B; Tocher JH; Fielden EM; Adams GE; Stratford IJ
Anticancer Drug Des; 1993 Dec; 8(6):439-61. PubMed ID: 8286012
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Xia Q; Zhang L; Zhang J; Sheng R; Yang B; He Q; Hu Y
Eur J Med Chem; 2011 Mar; 46(3):919-26. PubMed ID: 21281992
[TBL] [Abstract][Full Text] [Related]
26. Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors.
Hay MP; Shin HN; Wong WW; Sahimi WW; Vaz ATD; Yadav P; Anderson RF; Hicks KO; Wilson WR
Molecules; 2019 Jul; 24(14):. PubMed ID: 31295864
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and anti-cancer activity of 2,6-disubstituted N-methylpiperidine derivatives and their N-oxides.
Henderson ND; Plumb JA; Robins DJ; Workman P
Anticancer Drug Des; 1996 Sep; 11(6):421-38. PubMed ID: 8836108
[TBL] [Abstract][Full Text] [Related]
28. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Yin H; Xu Y; Qian X; Li Y; Liu J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of the cytotoxicity of the anticancer agent tirapazamine by benzotriazine N-oxides: the role of redox equilibria.
Anderson RF; Shinde SS; Hay MP; Denny WA
J Am Chem Soc; 2006 Jan; 128(1):245-9. PubMed ID: 16390153
[TBL] [Abstract][Full Text] [Related]
30. Novel N-oxides as bioreductive drugs.
Naylor MA
Oncol Res; 1994; 6(10-11):483-91. PubMed ID: 7620216
[TBL] [Abstract][Full Text] [Related]
31. Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: comparison with other hypoxia-activated prodrugs.
Hunter FW; Wang J; Patel R; Hsu HL; Hickey AJ; Hay MP; Wilson WR
Biochem Pharmacol; 2012 Mar; 83(5):574-85. PubMed ID: 22182429
[TBL] [Abstract][Full Text] [Related]
32. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of some steroidal oximes as cytotoxic agents: structure/activity studies (I).
Cui JG; Fan L; Huang LL; Liu HL; Zhou AM
Steroids; 2009 Jan; 74(1):62-72. PubMed ID: 18838084
[TBL] [Abstract][Full Text] [Related]
34. Characterization of radicals formed following enzymatic reduction of 3-substituted analogues of the hypoxia-selective cytotoxin 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
Shinde SS; Maroz A; Hay MP; Patterson AV; Denny WA; Anderson RF
J Am Chem Soc; 2010 Mar; 132(8):2591-9. PubMed ID: 20141134
[TBL] [Abstract][Full Text] [Related]
35. Structure-based design and synthesis of tricyclic IAP (Inhibitors of Apoptosis Proteins) inhibitors.
Hird AW; Aquila BM; Block MH; Hennessy EJ; Kamhi VM; Omer CA; Laing NM; Saeh JC; Sha L; Yang B
Bioorg Med Chem Lett; 2014 Apr; 24(7):1820-4. PubMed ID: 24631189
[TBL] [Abstract][Full Text] [Related]
36. Oxidation of 2-deoxyribose by benzotriazinyl radicals of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
Shinde SS; Anderson RF; Hay MP; Gamage SA; Denny WA
J Am Chem Soc; 2004 Jun; 126(25):7865-74. PubMed ID: 15212534
[TBL] [Abstract][Full Text] [Related]
37. Syntheses and structure-activity relationships in cytotoxicities of 13-substituted quaternary coptisine derivatives.
Zhang ZH; Deng AJ; Wu LQ; Fang LH; Yu JQ; Li ZH; Yuan TY; Wang WJ; Du GH; Qin HL
Eur J Med Chem; 2014 Oct; 86():542-9. PubMed ID: 25203783
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro.
Carroll WA; Agrios KA; Altenbach RJ; Buckner SA; Chen Y; Coghlan MJ; Daza AV; Drizin I; Gopalakrishnan M; Henry RF; Kort ME; Kym PR; Milicic I; Smith JC; Tang R; Turner SC; Whiteaker KL; Zhang H; Sullivan JP
J Med Chem; 2004 Jun; 47(12):3180-92. PubMed ID: 15163197
[TBL] [Abstract][Full Text] [Related]
39. Novel benzopyridothiadiazepines as potential active antitumor agents.
Lebegue N; Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Chavatte P; Berthelot P
J Med Chem; 2005 Nov; 48(23):7363-73. PubMed ID: 16279796
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]